International Day of Radiology 2016 Interview on Breast Imaging Australia / Dr. Michelle Reintals. Breast imaging in Australia
|
|
- Augustine Norman
- 5 years ago
- Views:
Transcription
1 International Day of Radiology 2016 Interview on Breast Imaging Australia / Dr. Michelle Reintals Breast imaging in Australia An interview with Dr. Michelle Reintals, Director of Breast at IMED Queensland SouthernX Radiology in Brisbane, Australia, Chair of the Breast Imaging Reference Group (BIRG) of the Royal Australian and New Zealand College of Radiologists, and State Screening Program Radiology Coordinator at BreastScreen South Australia. European Society of Radiology: Breast imaging is widely known for its role in the detection of breast cancer. Could you please briefly outline the advantages and disadvantages of the various modalities used in this regard? Michelle Reintals: Biennial mammography (breast x-ray) is considered the gold standard for screening for breast cancer in women aged Breast Screen Australia has been providing mammographic screening for over 20 years, with proven benefits shown by improved survival rates from the early detection of breast cancer. If an abnormality is found on a mammogram or a woman has a symptom, then ultrasound is routinely performed for further investigation. Mammograms can be used to identify mass lesions, distortion of normal structures and calcifications, whereas ultrasound is used to characterise the abnormality by determining for example if it is solid, cystic, infiltrating or vascular. As it is operator dependant and time consuming, ultrasound may not detect pre-malignant calcifications in the breast that may only be seen on mammography, and some small cancers may not be appreciated. In addition, ultrasound may detect many benign lesions such as inflamed cysts and this may result in the patient having unnecessary biopsies to prove they are benign. As with any technology, there are advantages and disadvantages. The pitfalls of mammography include slow growing lesions where stability is reassuring for a benign lesion and lack of detection of certain types of breast cancers, which may be difficult to perceive due to the nature of their biology and growth pattern. Another limitation of mammography that is becoming topical amongst breast professionals is breast density. The ability to detect breast cancer depends upon subtle differences in contrast density between the normal breast tissue and the cancer. It is for this reason that women with high breast density are amongst the most difficult mammograms to read, as the cancers may be hidden by the normal background dense tissue. To compound this dilemma, we also know that high breast density is associated with an increased risk of breast cancer. So not only are the mammograms more difficult to read, as the cancers are camouflaged by the normal surrounding tissue, but these women also have reduced detection of breast cancer on routine screening. For this reason, and also applicable to women with a strong family history of breast or ovarian cancer, additional imaging technologies may be suggested for screening. These adjunct technologies include digital breast tomosynthesis (DBT) and breast magnetic resonance imaging (MRI). Tomosynthesis obtains a series of low-dose x-rays through the breast at various angles, reducing the problem of summation effect, which is common in women with dense breasts. Its benefits include increased cancer detection rates, a reduction in the number of extra mammography views and a reduction in the use of ultrasound where the mammography abnormality is cleared. The disadvantage is the extra radiation dose if it is performed in combination with mammography and the extra compression and discomfort for the women. The radiologist s reading time is significantly increased, as over 400 images are typically generated, compared with the standard four images with a mammogram.
2 Breast MRI is independent of breast density; it relies upon both the character of the tissue and the blood supply and enhancement pattern of an abnormality within the breast. It is highly sensitive in the detection of breast cancer. The disadvantages of MRI are that it may detect many benign lesions that require further work-up with ultrasound and the possibility of biopsy, all contributing to patient anxiety. It requires an intravenous injection of contrast media and is therefore an invasive procedure. Also, recent reports have shown that the intravenous contrast medium used has the potential to accumulate in certain parts of the brain. Whilst gadolinium injection is not specific to breast MRI, the dilemma is that it is as yet unknown if this is significant or has long-term repercussions for the patient, and if so, what they may be. Given breast MRI is often performed routinely every year for women at high risk of breast cancer and in many circumstances from a young age (e.g. 25 years old) if known BRCA gene carriers, this has raised concerns. As a consequence of these recent findings, it is recommended that a cyclic structure gadolinium chelate is used in preference to a linear structure agent. ESR: Early detection of breast cancer is the most important issue for reducing mortality, which is one reason for large-scale screening programmes. What kind of programmes are in place in your country and where do you see the advantages and possible disadvantages? MR: Australia s population-based screening programme, Breast Screen Australia (BSA) has been in existence since The programme invites women of the screening target group between the ages of to attend for a biennial screening mammogram. Statistics have shown a benefit from screening with a significant reduction in mortality rates. In 1991, when BSA commenced, 68 women per 100,000 died from breast cancer, compared with 44 per 100,000 in The BSA Evaluation 2009 programme report demonstrated mortality reduction of 21 28% in the target aged women, in line with earlier randomised controlled trials undertaken in Europe. Australia has six states, and each state provides an individual screening programme, which is held accountable to a high standard of practice by the National Accreditation Standards, under the jurisdiction of the national screening programme BSA. The challenges that a population-based screening programme experience are numerous, and a country the size of Australia introduces many additional challenges that are unique, including access for rural and indigenous populations and satisfactory participation among the target-aged, resident female population. Mobile bus units travel around Australia, which assists in breaking down the barriers of accessibility. Participation is centred around breast cancer awareness, which the Australian government promotes through the national screening programme. Participation rates are typically around 55% for the screening target group. Other non-government programmes, such as the McGrath Foundation, contribute significantly to the awareness of breast cancer through sponsored events and October Breast Cancer Awareness month. The benefits of a screening programme have been demonstrated with a reduction in mortality rates, but potential disadvantages of a population-based screening programme also exist. These include reduced accuracy of cancer detection in women with high mammographic breast density. It is recognised that women with a high risk of breast cancer due to their family history or those women who are BRCA gene carriers, are eligible for annual mammographic screening. So this raises the question, should we be reporting routinely on breast density? Should we be offering personalised screening pathways, incorporating family history, breast density, etc.? Should we be offering magnetic resonance imaging to women with high mammographic breast density? This is a complex issue, with concerns relating to funding and resources, and patient anxiety. ESR: The most common method for breast examination is mammography. When detecting a possible malignancy, which steps are taken next? Are other modalities used for confirmation? MR: The imaging guidelines recommended for standard practice include the use of multiple modalities, and the individual application depends upon many factors, including the nature of the lesion detected.
3 A standard mammogram that reveals a lesion will be further investigated with spot compression views if the abnormality is a mass, density or distortion, or with magnification views if calcification. Typically ultrasound will then be performed to assess for a mass or infiltrative lesion, evidence of skin or chest wall involvement and if there is lymph node spread. Fine needle aspiration or core biopsy may be performed, usually under ultrasound guidance, however, if the abnormality is not visualised on ultrasound (e.g. calcifications), then it is common practice to perform vacuum-assisted core biopsy on calcifications under mammogram guidance. A radio-opaque site marker may be placed at the time of biopsy, where appropriate, in order to mark the site of biopsy and assist in localisation if excision of the lesion is required. They are typically used when a lesion is almost completely excised at biopsy or difficult to see under all imaging modalities. The site marker is a few millimetres in size, typically made of titanium or stainless steel, and is safe to remain within the breast long-term if the calcifications are benign. Once the diagnosis of breast cancer is made, staging investigations are carried out to identify any spread of disease to lymph nodes or organs. The treatment will depend upon this pre-operative staging. The staging investigations depend upon the size of the primary breast cancer. 1. Breast MRI may be performed for staging the size, extent of breast tumour burden, whether it is multifocal (multiple lesions within a breast quadrant) or multicentric (multiple lesions scattered throughout the breast), and if there is involvement in the contralateral (opposite) breast. 2. Chest x-ray, liver ultrasound or CT scan of the chest, abdomen and pelvis may be performed to assess for any spread to liver, lungs, or bone. 3. Whole body bone scan (WBBS) to assess for spread to bones. 4. Sentinel Node Biopsy (SNB) is performed on the day of surgery to identify the draining node from the site of the cancer, and this or the group of nodes are removed at the time of mastectomy or partial mastectomy. If these nodes prove to be malignant, then a second operation is required to remove any remaining nodes accessible in the axilla. ESR: Diagnosing disease might be the best-known use of imaging, but how can imaging be employed in other stages of breast disease management? MR: Imaging is used for screening for breast cancer and the diagnosis and staging of the extent of disease. There are circumstances where non-surgical treatment is administered. Neo-adjuvant treatment is used in advanced cancers where the size of the tumour or the extent of lymph node spread is reduced with chemotherapy prior to surgery. This approach may also be used to reduce tumour size to allow breast conserving surgery. Similarly, in frail or elderly patients who are not amenable to surgery, neo-adjuvant treatment, where the tumour is hormone sensitive (ER, PR positive), an aromatase inhibitor is used to locally control or reduce the primary cancer. In all these instances, the tumour burden and extent of nodal disease is monitored at regular intervals, to ensure that the treatment is effective and the disease is responding to the chemotherapy or hormone treatment. If the tumour burden is increasing, then hormonal or chemotherapy agents can be altered. The imaging options available to closely monitor the tumour and nodal response are mammography, ultrasound and MRI. If there is distant spread of disease to common sites such as liver, bone, lung, or brain, then tumour response is typically monitored by CT scans. ESR: What should patients keep in mind before undergoing an imaging exam? Do patients undergoing radiological exams generally experience any discomfort? MR: A patient undergoing a breast imaging exam will usually be anxious about the process and the possible outcome. As health professionals, we are trained to recognise and manage patient anxiety, and show a personal yet professional side to the patient and express empathy. It is important to be aware that some women experience significant discomfort during the mammogram and biopsy. It is important to explain the process and describe the experience when
4 obtaining the patient s consent, allowing time for any questions the patient may have regarding the procedure. There are some suggestions that can be made when a women books in for a routine screening mammogram, which may reduce the physical discomfort. This applies to pre-menopausal women, where exams may be better tolerated between days 7 to 14 of their menstrual cycle. If the study is being performed for symptoms, then timing with the menstrual cycle is unimportant, and imaging as soon as possible is optimal. It is vital that the health professional shows guidance and knowledge of the patient s circumstance and gives advice on the diagnosis and management. ESR: How do radiologists interpretations help in reaching a diagnosis? What kind of safeguards help to avoid mistakes in image interpretation and ensure consistency? MR: The detection of a breast cancer is a team approach and influenced by three main factors. These factors include image and display quality, mammogram positioning, and interpretation and perception of mammogram. 1. The quality and display of the image is influenced by image contrast resolution, display algorithms, and resolution of the computer monitors. 2. The quality of the acquired image is a challenge for the radiographer. The radiographer has the challenge of positioning the woman s breast such that all quadrants/axillae/infra-mammary folds/nipple are viewed, with minimal to no skin folds on view. The National guidelines for mammography stipulate required standards. These standards are monitored by the College of Radiologists via a Mammography Quality Assurance Program or in-house if within the national screening programme, by routine review of images and by giving constant feedback and ongoing education to the mammographers in the quality assurance programme. 3. The reading of a mammogram by a radiologist is task that involves both perception and interpretation. Whilst failure to detect breast cancer can result from multiple factors, it is important for the radiologist to be aware of any potential missed or interval cancers, as they may be due to a perceptive or interpretive error. The larger the number of mammograms read by a radiologist, typically the higher their cancer detection rate and the lower the missed cancer rate. Regular quality assurance sessions to review missed and interval cancers, multidisciplinary meetings, and peer education meetings, are important methods of improving cancer detection and maintaining a high quality of reading skill. ESR: When detecting a malignancy, how is the patient usually informed and by whom? MR: The primary care giver typically informs the patient of their diagnosis of breast cancer. This will depend upon the circumstance and whether the imaging was screening or diagnostic. If screening was performed by the national screening programme, then the common scenario is that the patient attends a results clinic a couple of days after the assessment clinic workup and biopsy of the abnormality. Within the screening programme, the diagnosis of breast cancer is typically given by a breast surgeon. In the diagnostic setting, patients in Australia may be assessed within either the public hospital or private imaging practice setting. Typically the doctor referring the woman for assessment will deliver the final pathology result to the patient and arrange referral to a breast surgeon for management. ESR: Some imaging technology, such as x-ray and CT, uses ionising radiation. How do the risks associated with radiation exposure compare with the benefits? How can patient safety be ensured when using these modalities? MR: Imaging should only ever be performed if there is likely to be a clear benefit, and that the potential benefit outweighs any possible risk from the procedure. There has been a clear benefit shown in the Australian screening programme, with a reduction in breast cancer deaths between 21 28%. Whilst this is significant, there is the potential issue of over-diagnosis. This refers to those
5 cancers which may not result in patient death if untreated. Whilst a discussion point, it remains a dilemma, as currently there is no way of accurately determining pre-operatively which cancers are harmful versus those that are not harmful, if left untreated. ESR: How aware are patients of the risks of radiation exposure? How do you address the issue with them? MR: The internet provides general information on a range of topics, including medical information, and therefore many patients will research what procedure their doctor has requested, and inform themselves prior to their appointment. Radiation risk versus benefit is topical and is the subject of many questions from patients attending for a mammogram. It is the health provider s role to explain these risks and benefits and to allow the patient to ultimately decide what their preference is. The Royal Australian and New Zealand College of Radiologists has a teaching portal available to members and also a general consumer section for the public, called Inside Radiology, where there is information on such topics. Breast imaging information at Inside Radiology is searched by approximately 13,000 people per month from 180 countries, and the website has approximately 200,000 visits per month. The optimal service is one where the principle of ALARA is adopted: ALARA is the acronym for the phrase As Low As Reasonably Achievable, which refers to the practice of keeping radiation doses as low as is practical to achieve a useful quality image. ESR: How much interaction do you usually have with your patients? Could this be improved and, if yes, how? MR: There is a distinction in service provision between population and personalised private breast screening. In a population screening programme, there is no individualised service based on risk factors or personal contact with the patient. The patient undergoes their routine mammogram and receives her result via mail. If there is an abnormality seen by two readers interpreting the image, then the patient is recalled for assessment, at which time she will be given the results by a health professional in a results clinic setting. In a personalised private breast screening programme, there is typically a clinical breast exam done by either a breast physician or breast surgeon and a mammogram read by a breast radiologist. If there is a symptom then further diagnostic workup will be done, which may include ultrasound, MRI, and biopsy. ESR: How do you think breast imaging will evolve over the next decade and how will this change patient care? How involved are radiologists in these developments and what other physicians are involved in the process? MR: Breast imaging is continually undergoing significant changes, improvements and upgrades. For many years analogue mammography and ultrasound were routine. In recent years there has been a transition to computer radiography (CR) and more recently to digital radiography (DR) with tomosynthesis and magnetic resonance imaging (MRI). We have also seen the transition from fine needle aspiration biopsy (FNA) to core biopsy and vacuum-assisted core biopsy, due to advances in technology and biopsy equipment, and changes in management that require histopathology and receptor status of the tumour prior to the decision on surgery. There are also software programmes available that assess the mammographic breast density, and with this awareness comes a consideration for adjunct screening such as tomosynthesis, MRI or ultrasound where deemed appropriate. These adjunct imaging techniques are also used in the setting of known risk factors such as family history and gene carrier status. Screening imaging techniques are used to detect early, small, curable cancers. Ultimately, despite these efforts, there remains a relatively high interval cancer rate, where cancers present between screening mammograms.
6 Whilst the mortality rates from breast cancer are decreasing, the incidence of breast cancer is increasing. Perhaps the future developments will look at how to reduce the interval cancer rates, by determining which are the cancers that cause this. We are already moving towards screening women based upon their breast density, having recognised this is a separate risk factor as well as a compounding factor in the reduced sensitivity of mammographic screening. Should we be offering personalised screening pathways, incorporating family history, genetics, breast density, etc.? Michelle Reintals, MBBS, FRANZCR, is an Australian radiologist, specialised in breast imaging, having undertaken fellowships at BreastScreen South Australia and observorships and sabbaticals in breast imaging at Memorial Sloan Kettering Cancer Center NYC, Brigham Hospital Boston, Curie Institute Paris and the Brussels Screening Program, during her 14-year career. Dr. Reintals has worked in both public and private breast practices in South Australia and Australia in clinical, educational and administrative capacities, holding the role of State Screening Program Radiology Coordinator at BreastScreen South Australia. She has recently relocated to Brisbane to work for IMED Queensland SouthernX Radiology as Director of Breast. Currently she is the Chair of the Breast Imaging Reference Group (BIRG) of the Royal Australian and New Zealand College of Radiologists and a Committee member of the Breast Imaging Group (BIG) and Mammographic Quality Assurance Program MQAP of the Royal Australian and New Zealand College of Radiologists and Australasian Society for Breast Disease (ASBD). Dr. Reintals undertook a study into polyimplant prostheses in 2012 in South Australia with Prof. Michael Middleton MD, from San Diego. She has authored numerous papers on breast diagnostics and radiology techniques for Australasian conference presentations and publications, and assists in the tutoring and fellowships of young breast radiologists.
Policy Library Clinical Advantages of Digital Breast Tomosynthesis in Symptomatic Patients
Policy Library Clinical Advantages of Digital Breast Tomosynthesis in Symptomatic Patients Version: 1 Approved by: Faculty of Clinical Radiology Council Date of approval: Click and type: day month and
More informationBreastScreen Victoria Annual Statistical Report
BreastScreen Victoria Annual Statistical Report 005 Produced by: BreastScreen Victoria Coordination Unit Level, Pelham Street, Carlton South Victoria 05 PH 0 9660 6888 FX 0 966 88 EM info@breastscreen.org.au
More informationDetailed Program of the second BREAST IMAGING AND INTERVENTIONS PROGRAM am am : Clinician s requirements from breast imaging
Detailed Program of the second BREAST IMAGING AND INTERVENTIONS PROGRAM 2012 Day one, 2 nd November BREAST IMAGING AND INTERVENTIONS PROGRAM 2012 9.00 AM 9.10 am Introduction 9.10 am - 9.30 am : Clinician
More informationBreast Imaging & You
Breast Imaging & You What s Inside: Breast Imaging... 2 Digital Breast Tomosynthesis (DBT) mammograms... 4 Breast cancer screening... 6 Dense breast tissue... 8 Automated Breast Ultrasound (ABUS)... 9
More informationBreast Magnetic Resonance Imaging (MRI) Westmead Breast Cancer Institute
Breast Magnetic Resonance Imaging (MRI) Westmead Breast Cancer Institute What is breast MRI? Breast MRI is a technique that uses a magnetic field to create an image of the breast tissue, using hundreds
More informationBreast Imaging & You
Breast Imaging & You What s Inside: Breast Imaging... 2 Digital Breast Tomosynthesis (DBT) mammograms... 4 Breast cancer screening... 6 Dense breast tissue... 8 Automated breast ultrasound (ABUS)... 9
More informationBreast Health and Imaging Glossary
Contact: Lorna Vaughan HerSpace Breast Imaging & Biopsy Associates 300 State Route 35 South W. Long Branch, NJ 07764 732-571-9100, ext. 104 lorna@breast-imaging.com Breast Health and Imaging Glossary Women
More informationBreast Cancer Diagnosis, Treatment and Follow-up
Breast Cancer Diagnosis, Treatment and Follow-up What is breast cancer? Each of the body s organs, including the breast, is made up of many types of cells. Normally, healthy cells grow and divide to produce
More informationThe Australian BreastScreen workforce: a snapshot
Original article Volume 59 (1) 2012 The Australian BreastScreen workforce: a snapshot S Moran British Diploma of Diagnostic Radiography H Warren Forward Bsc (Hons), Phd Medical Radiation Science Hunter
More informationEpworth Healthcare Benign Breast Disease Symposium. Sat Nov 12 th 2016
Epworth Healthcare Benign Breast Disease Symposium Breast cancer is common Sat Nov 12 th 2016 Benign breast disease is commoner, and anxiety about breast disease commoner still Breast Care Campaign UK
More informationBreast Cancer Imaging
Breast Cancer Imaging I. Policy University Health Alliance (UHA) will cover breast imaging when such services meet the medical criteria guidelines (subject to limitations and exclusions) indicated below.
More informationBreast Cancer. What is breast cancer?
Scan for mobile link. Breast Cancer Breast cancer is a malignant tumor in or around breast tissue. It usually begins as a lump or calcium deposit that develops from abnormal cell growth. Most breast lumps
More informationBreast Cancer. What is breast cancer?
Scan for mobile link. Breast Cancer Breast cancer is a malignant tumor in or around breast tissue. It usually begins as a lump or calcium deposit that develops from abnormal cell growth. Most breast lumps
More informationBreastScreen Victoria Annual Statistical Report
BreastScreen Victoria Annual Statistical Report 29 BREASTSCREEN VICTORIA: ANNUAL STATISTICAL REPORT, 29 Produced by: BreastScreen Victoria Coordination Unit Level, 3 Pelham Street, Carlton South Victoria
More informationIntroduction 1. Executive Summary 5
Roman_pages 20-09-2005 21:01 Pagina IX Table of contents Introduction 1 Executive Summary 5 1. Epidemiological guidelines for quality assurance in breast cancer screening 15 1.10 Introduction 17 1.20 Local
More informationBreastScreen Victoria Annual Statistical Report
BreastScreen Victoria Annual Statistical Report 2010 BREASTSCREEN VICTORIA: ANNUAL STATISTICAL REPORT, 2010 Produced by: BreastScreen Victoria Coordination Unit Level 1, 31 Pelham Street, Carlton South
More informationBreast Cancer Screening and Treatment Mrs Belinda Scott Breast Surgeon Breast Associates Auckland
Breast Cancer Screening and Treatment 2009 Mrs Belinda Scott Breast Surgeon Breast Associates Auckland BREAST CANCER THE PROBLEM 1.1 million women per year 410,000 deaths each year Increasing incidence
More informationBreastScreen Victoria Annual Statistical Report
BreastScreen Victoria Annual Statistical Report CONTENTS FIGURES AND TABLES... Figures... Tables... 3 INTRODUCTION... 5 SECTION MAXIMISING PARTICIPATION... 6 Program acceptance... 6 Eligibility... 6 Inviting
More informationEARLY DETECTION: MAMMOGRAPHY AND SONOGRAPHY
EARLY DETECTION: MAMMOGRAPHY AND SONOGRAPHY Elizabeth A. Rafferty, M.D. Avon Comprehensive Breast Center Massachusetts General Hospital Harvard Medical School Breast Cancer Screening Early detection of
More informationEARLY DETECTION: MAMMOGRAPHY AND SONOGRAPHY
EARLY DETECTION: MAMMOGRAPHY AND SONOGRAPHY Elizabeth A. Rafferty, M.D. Avon Comprehensive Breast Center Massachusetts General Hospital Harvard Medical School Breast Cancer Screening Early detection of
More information- The University of. - Student. Western Australia, Crawley, Western Australia
Title: Is Step Down Assessment of Screen Detected Lesions as Safe as Workup at a Metropolitan Assessment Centre? Authors Author name Degrees/ Fellowships Position Institution Phone Email Jade P Hughes
More informationThe early detection programme for breast cancer
Making a wellinformed decision The early detection programme for breast cancer Why are women offered a mammogram through the quality controlled screening programme? Women between 50 and 69 years of age
More informationANNEX 1 OBJECTIVES. At the completion of the training period, the fellow should be able to:
1 ANNEX 1 OBJECTIVES At the completion of the training period, the fellow should be able to: 1. Breast Surgery Evaluate and manage common benign and malignant breast conditions. Assess the indications
More informationThe Northern Ireland breast screening programme
The Northern Ireland breast screening programme Guide for health professionals The HSC offers breast screening to reduce the number of women who die from breast cancer. Breast cancer is the second most
More informationBreast Care Unit. 1. The triple assessment means that your breast will be examined by a doctor trained in breast disease.
Breast Care Unit Information for patients visiting a symptomatic breast clinic at the Medway NHS Foundation Trust Breast Care Unit, with breast symptoms. Your doctor has referred you to our symptomatic
More informationDiagnostic Dilemmas of Breast Imaging
Diagnostic Dilemmas of Breast Imaging Common Causes of Error in Breast Cancer Detection By: Jason Cord, M.D. Mammography: Initial Imaging The standard for detection of breast cancer Screening mammography
More informationTHE BREAST CENTER AT MONTEFIORE NYACK HOSPITAL
THE BREAST CENTER AT MONTEFIORE NYACK HOSPITAL COMPLETE BREAST CARE FROM THE TEAM THAT CARES I don t think I could get better care, more support, or encouragement at any of the bigger hospitals or cancer
More informationMammographic imaging of nonpalpable breast lesions. Malai Muttarak, MD Department of Radiology Chiang Mai University Chiang Mai, Thailand
Mammographic imaging of nonpalpable breast lesions Malai Muttarak, MD Department of Radiology Chiang Mai University Chiang Mai, Thailand Introduction Contents Mammographic signs of nonpalpable breast cancer
More informationMammography. What is Mammography?
Scan for mobile link. Mammography Mammography is a specific type of breast imaging that uses low-dose x-rays to detect cancer early before women experience symptoms when it is most treatable. Tell your
More informationROLE OF MRI IN SCREENING, DIAGNOSIS AND MANAGEMENT OF BREAST CANCER. B.Zandi Professor of Radiology
ROLE OF MRI IN SCREENING, DIAGNOSIS AND MANAGEMENT OF BREAST CANCER B.Zandi Professor of Radiology Introduction In the USA, Breast Cancer is : The Most Common Non-Skin Cancer The Second Leading cause of
More informationBreast Cancer. Most common cancer among women in the US. 2nd leading cause of death in women. Mortality rates though have declined
Breast Cancer Most common cancer among women in the US 2nd leading cause of death in women Mortality rates though have declined 1 in 8 women will develop breast cancer Breast Cancer Breast cancer increases
More informationComplete breast care from the team that cares. Breast Center
Breast Center Complete breast care from the team that cares. Imaging Appointment: 845.348.8551 Surgical Consultation: 845.348.8507 nyackhospital.org/breastcenter 1 Complete breast care from the team that
More informationScreening for Breast Cancer
Understanding Task Force Recommendations Screening for Breast Cancer U.S. Preventive Services Task Force (Task Force) has issued a final recommendation statement on Screening for Breast Cancer. se final
More informationScreening Mammograms: Questions and Answers
CANCER FACTS N a t i o n a l C a n c e r I n s t i t u t e N a t i o n a l I n s t i t u t e s o f H e a l t h D e p a r t m e n t o f H e a l t h a n d H u m a n S e r v i c e s Screening Mammograms:
More informationBenign Intraparenchymal Scarring in the DBT Era
Benign Intraparenchymal Scarring in the DBT Era David Gruen, MD, MBA, FACR Director of Women s Imaging, Stamford Health, Stamford, CT With the advent of Digital Breast Tomosynthesis (DBT or 3D mammography),
More informationContrast-Enhanced Spectral Mammography
Contrast-Enhanced Spectral Mammography Illuminating Breast Cancer Detection SenoBright HD TM gehealthcare.com/senobright Mammography is the most reliable imaging technique for breasts, but limitations
More informationBreast Cancer. Saima Saeed MD
Breast Cancer Saima Saeed MD Breast Cancer Most common cancer among women in the US 2nd leading cause of death in women 1 in 8 women will develop breast cancer Incidence/mortality rates have declined Breast
More informationMelissa Hartman, DO Women s Health Orlando VA Medical Center
Melissa Hartman, DO Women s Health Orlando VA Medical Center Most common non-skin cancer and Second deadliest cancer in women Majority are diagnosed by abnormal screening study An approach to breast cancer
More informationBreast Tomosynthesis. What is breast tomosynthesis?
Scan for mobile link. Breast Tomosynthesis Breast tomosynthesis is an advanced form of mammography, a specific type of breast imaging that uses low-dose x-rays to detect cancer early when it is most treatable.
More informationNational Breast Cancer Audit next steps. Martin Lee
National Breast Cancer Audit next steps Martin Lee National Cancer Audits Current Bowel Cancer Head & Neck Cancer Lung cancer Oesophagogastric cancer New Prostate Cancer - undergoing procurement Breast
More informationMammograms, Ultrasounds, MRI: Who gets what and why?
Mammograms, Ultrasounds, MRI: Who gets what and why? Beast MRI Ultrasound Mammogram Kavita Dhamanaskar, MBBS, DNB, FRCP(C) Associate Professor @ McMaster University Radiologist @ Juravinski Hospital and
More informationAdvice Statement 005/18 April 2018
Advice Statement 005/18 April 2018 In asymptomatic women attending for breast screening, what is the clinical and cost effectiveness of digital breast tomosynthesis (DBT) in addition to full-field digital
More informationBREAST IMAGING and NEW IMAGING MODALITIES- A Surgeons view
BREAST IMAGING and NEW IMAGING MODALITIES- A Surgeons view DR CHANTEL THORNTON SPECIALIST BREAST CANCER SURGEON BMSc (hons) MBBS (hons) FRACS Epworth Hospital, Richmond- Agora Centre for Women s Health
More informationWhat is Cancer? Petra Ketterl, MD Medical Oncology and Functional Medicine
What is Cancer? Petra Ketterl, MD Medical Oncology and Functional Medicine What is Cancer? Layman s terms: cancer starts when cells grow out of control (in any place in the body) and crowd out normal cells
More informationCase 1. BREAST CANCER From Diagnosis to Treatment: The Role of Primary Care
BREAST CANCER From Diagnosis to Treatment: The Role of Primary Care Leah Karliner, MD MAS University of California San Francisco Primary Care Medicine Update 2009 April 2009 Case 1 AR, a 60 year old African
More informationMammography. What is Mammography? What are some common uses of the procedure?
Mammography What is Mammography? Mammography is a specific type of imaging that uses a low-dose x-ray system to examine breasts. A mammography exam, called a mammogram, is used to aid in the early detection
More informationmaking a referral for breast imaging Standard Operating Procedure
Document Control Title Reporting Radiographer Author Directorate Surgery Date Version Issued 0.1 May 2016 Status Draft Author s job title Reporting Radiographer Department Breast Imaging Comment / Changes
More informationBreast Imaging: Multidisciplinary Approach. Madelene Lewis, MD Assistant Professor Associate Program Director Medical University of South Carolina
Breast Imaging: Multidisciplinary Approach Madelene Lewis, MD Assistant Professor Associate Program Director Medical University of South Carolina No Disclosures Objectives Discuss a multidisciplinary breast
More informationBreast Cancer. Common kinds of breast cancer are
Breast Cancer A breast is made up of three main parts: glands, ducts, and connective tissue. The glands produce milk. The ducts are passages that carry milk to the nipple. The connective tissue (which
More informationBreast Cancer Screening
Scan for mobile link. Breast Cancer Screening What is breast cancer screening? Screening examinations are tests performed to find disease before symptoms begin. The goal of screening is to detect disease
More informationGeneral Information Key Points
The content of this booklet was adapted from content originally published by the National Cancer Institute. Male Breast Cancer Treatment (PDQ ) Patient Version. Updated September 29,2017. https://www.cancer.gov/types/breast/patient/male-breast-treatment-pdq
More informationBreastScreen Queensland Gold Coast Service. General Practice Nurses Forum Thursday 4 May 2017
BreastScreen Queensland Gold Coast Service General Practice Nurses Forum Thursday 4 May 2017 BreastScreen Queensland Gold Coast Service General Practice Nurses Forum Thursday 4 May 2017 BreastScreen in
More informationThe Radiology Aspects
REQUIREMENTS FOR INTERNATIONAL ACCREDITATION OF BREAST CENTERS/UNITS The Radiology Aspects Miri Sklair-Levy, Israel RADIOLOGY GUIDELINES FOR QUALITY ASSURANCE IN BREAST CANCER SCREENING AND DIAGNOSIS Radiologists
More informationBreast Cancer: Selected Topics for the Primary Care Clinician
Breast Cancer: Selected Topics for the Primary Care Clinician Leah Karliner, MD MAS October 2009 Primary Care Medicine: Principles and Practice OUTLINE Incidence and Mortality Risk Factors and Risk Reduction/Prevention
More informationF r e q u e n t l y A s k e d Q u e s t i o n s. Mammograms
Mammograms Q: What is a mammogram? A: A mammogram is a safe, low-dose x-ray exam of the breasts to look for changes that are not normal. The results are recorded on x-ray film or directly into a computer
More informationImaging in breast cancer. Mammography and Ultrasound Donya Farrokh.MD Radiologist Mashhad University of Medical Since
Imaging in breast cancer Mammography and Ultrasound Donya Farrokh.MD Radiologist Mashhad University of Medical Since A mammogram report is a key component of the breast cancer diagnostic process. A mammogram
More informationTable of contents. Page 2 of 40
Page 1 of 40 Table of contents Introduction... 4 1. Background Information... 6 1a: Referral source for the New Zealand episodes... 6 1b. Invasive and DCIS episodes by referral source... 7 1d. Age of the
More informationProgramme Report
Programme Report 2015-2016 Contents Introduction from the Head of Screening, National Screening Service 2 Highlights of 2015-2016 4 Programme report 5 References 19 Introduction from the Head of Screening,
More informationFY16 BCCS Reimbursement Rates and Billing Guidelines Appendix B 2
FY16 BCCS Reimbursement Rates and Billing Guidelines Appendix B 2 77053 Mammary ductogram or galactogram, single duct, Global Fee $59.05 May be billed with 77055, G0206, 77056, G0204, 76641, 76642 Billable
More informationAdvances in Breast Cancer Diagnosis and Treatment. Heidi Memmel, MD FACS Surgical Director of Caldwell Breast Center September 26, 2015
Advances in Breast Cancer Diagnosis and Treatment Heidi Memmel, MD FACS Surgical Director of Caldwell Breast Center September 26, 2015 Advances in Breast Cancer Diagnosis and Treatment Recommendations
More informationPhyllodes tumours: borderline and malignant
Phyllodes tumours: borderline and malignant This booklet is for people who would like more information about borderline or malignant phyllodes tumours. It describes what they are, the symptoms, how a diagnosis
More informationCan Digital Breast Tomosynthesis(DBT) Perform Better than Standard Digital Mammography Workup in a Breast Cancer Assessment Clinic?
Can Digital Breast Tomosynthesis(DBT) Perform Better than Standard Digital Mammography Workup in a Breast Cancer Assessment Clinic? Accepted for publication in European Radiology Authors: S Mall, J Noakes,
More informationBreast imaging in general practice
Breast series CLINICAL PRACTICE Breast imaging in general practice Nehmat Houssami, MBBS, FAFPHM, FASBP, PhD, is Associate Clinical Director, NSW Breast Cancer Institute, Westmead Hospital, Honorary Senior
More informationFinancial Disclosures
Financial Disclosures 3D Mammography: The Latest Developments in the Breast Imaging Arena I have no financial disclosures Dr. Katharine Lampen-Sachar Breast and Body Radiologist Radiology Associates of
More informationBreast Surgery When Less is More and More is Less. E MacIntosh, MD June 6, 2015
Breast Surgery When Less is More and More is Less E MacIntosh, MD June 6, 2015 Presenter Disclosure Faculty: E. MacIntosh Relationships with commercial interests: None Mitigating Potential Bias Not applicable
More informationHere are examples of bilateral analog mammograms from the same patient including CC and MLO projections.
Good afternoon. It s my pleasure to be discussing Diagnostic Breast Imaging over the next half hour. I m Wei Yang, Professor of Diagnostic Radiology and Chief, the Section of Breast Imaging as well as
More informationThe London BreasT CenTre
The London Breast Centre Contents Introduction 4 One-Stop Breast Care Clinic 5 Common breast problems 6 Hereditary breast cancer 8 Breast cancer and cancer screening 9 Breast diagnostic tests 10 Breast
More informationUpper GI Malignancies Imaging Guidelines for the Management of Gastric, Oesophageal & Pancreatic Cancers 2012
Upper GI Malignancies Imaging Guidelines for the Management of Gastric, Oesophageal & Pancreatic Cancers 2012 Version Control This is a controlled document please destroy all previous versions on receipt
More informationBreastScreen Aotearoa Annual Report 2015
BreastScreen Aotearoa Annual Report 2015 EARLY AND LOCALLY ADVANCED BREAST CANCER PATIENTS DIAGNOSED IN NEW ZEALAND IN 2015 Prepared for Ministry of Health, New Zealand Version 1.0 Date November 2017 Prepared
More informationMammography is a most effective imaging modality in early breast cancer detection. The radiographs are searched for signs of abnormality by expert
Abstract Methodologies for early detection of breast cancer still remain an open problem in the Research community. Breast cancer continues to be a significant problem in the contemporary world. Nearly
More informationContrast-Enhanced Spectral Mammography helps to improve breast cancer diagnostics
GE Healthcare Contrast-Enhanced Spectral Mammography helps to improve breast cancer diagnostics SenoBright TM mammography, Midwest U.S. hospital Simple test benefits clinicians and patients A hospital
More informationBreast Cancer Screening Factsheet
Breast Cancer Screening What does breast cancer screening entail? The National Breast Cancer Screening Programme is designed for women between 50 and 75 years of age. Once every 2 years, women in this
More informationGe elastography cpt codes
Ge elastography cpt codes Aetna considers digital mammography a medically necessary acceptable alternative to film mammography. Currently, there are no guideline recommendations from leading medical professional
More informationBreast Imaging! Ravi Adhikary, MD!
Breast Imaging! Ravi Adhikary, MD! ACS Estimated Cancers Statistics 2014! Breast! New Cases in Women! 232,670 (+67,570 in situ)! Deaths in Women! 40,000! Colon! 48,380! 24,040! Cervical! 12,360! 4,020!
More informationWOMENCARE A Healthy Woman is a Powerful Woman (407) Mammography
Mammography WOMENCARE A Healthy Woman is a Powerful Woman (407) 898-1500 Mammography is an X-ray technique used to study the breasts. It can help doctors find breast cancer at an early stage (when treatment
More informationBR 1 Palpable breast lump
BR 1 Palpable breast lump Palpable breast lump in patient 40 years of age or above MMG +/- spot compression or digital breast tomosynthesis over palpable findings Suspicious or malignant findings (BIRADS
More informationBreast health and screening
Breast health and screening Dr Kathy Wong MBBS (HK), FRCR (UK), FHKCR FHKAM (Radiology) Clinical Radiologist Department of Diagnostic and Interventional Radiology Kwong Wah Hospital Questions regarding
More informationA Breast Surgeon s Use of Three Dimensional Specimen Tomosynthesis
A Breast Surgeon s Use of Three Dimensional Specimen Tomosynthesis Cary S. Kaufman MD, FACS Associate Clinical Professor of Surgery A Breast Surgeon s Use of Three Dimensional Specimen Tomosynthesis Cary
More informationCurrent issues and controversies in breast imaging. Kate Brown, South GP CME 2015
Current issues and controversies in breast imaging Kate Brown, South GP CME 2015 JUDICIOUS USE OF RESOURCES IN REFERRALS FOR BREAST IMAGING THE DILEMMA How do target referrals for breast imaging? Want
More informationThis information explains the advice about familial breast cancer (breast cancer in the family) that is set out in NICE guideline CG164.
Familial breast cancer (breast cancer in the family) Information for the public Published: 1 June 2013 nice.org.uk About this information NICE guidelines provide advice on the care and support that should
More information1. Screening, Diagnosis and Surgical Management of Breast Cancer
1. Screening, Diagnosis and Surgical Management of Breast Cancer Dr Melanie Walker, MBBS, FRACS (Breast Surgeon) Oncoplastic Breast Surgery Combination of optimal cancer surgery with plastic surgical techniques
More informationCURRENT METHODS IN IMAGE GUIDED BREAST BIOPSY
CURRENT METHODS IN IMAGE GUIDED BREAST BIOPSY Stuart Silver April 24, 2004 OBJECTIVES Review development of current techniques Discuss stereotactic breast biopsy Discuss US guided breast biopsy 1 OBJECTIVES
More informationScreening Mammography as an example of Access to Healthcare A starting point for safe affordable medical treatment. Prof C A Benn
Screening Mammography as an example of Access to Healthcare A starting point for safe affordable medical treatment Prof C A Benn to screen or not to screen may be To be or not the to be question? re national
More informationHealth Bites Breast Cancer. Breast Cancer. Normal breast
Health Bites Breast Cancer Breast Cancer Normal breast The normal breast tissue varies in size and shape. The breasts rest in front of the rib cage. The breasts are made up of fatty tissue, milk ducts
More informationHenda s Law. Supplemental screening for women with dense breast tissue and increased risk
. Henda s Law Supplemental screening for women with dense breast tissue and increased risk The 2011 Texas Legislature passed House Bill 2102 which is effective 1st September 2011. The law is informally
More informationSurgery for Breast Cancer
Surgery for Breast Cancer 1750 Mastectomy - Petit 1894 Radical mastectomy Halsted Extended, Super radical mastectomy 1948 Modified radical mastectomy Patey 1950-60 WLE & RT Baclesse, Mustakallio 1981-85
More informationContrast enhanced spectral mammography: A literature review
Contrast enhanced spectral mammography: A literature review Poster No.: R-0172 Congress: RANZCR-AOCR 2012 Type: Authors: Keywords: DOI: Educational Exhibit S. Buzynski, D. Taylor; Perth/AU Breast, Digital
More informationPresented by: Lillian Erdahl, MD
Presented by: Lillian Erdahl, MD Learning Objectives What is Breast Cancer Types of Breast Cancer Risk Factors Warning Signs Diagnosis Treatment Options Prognosis What is Breast Cancer? A disease that
More informationBRCA genes and inherited breast and ovarian cancer. Information for patients
BRCA genes and inherited breast and ovarian cancer Information for patients This booklet has been written for people who have a personal or family history of breast and/or ovarian cancer that could be
More information[ Special Feature ] In-house breast imaging unit at KK Breast Centre. Busting the Fear for. Breast Cancer
In-house breast imaging unit at KK Breast Centre. Busting the Fear for Breast Cancer by Yah Yuen Tan Consultant Surgeon, KK Breast Centre KK Women s and Children s Hospital, Singapore Sze Yiun Teo Consultant
More informationStandard Breast Imaging Modalities. Lilian Wang, M.D. Breast Imaging Section Department of Radiology Northwestern Medicine
Standard Breast Imaging Modalities Lilian Wang, M.D. Breast Imaging Section Department of Radiology Northwestern Medicine Overview Standard breast imaging modalities Mammography Ultrasound MRI Imaging
More informationBreast Cancer in Women
The Crawford Clinic 1900 Leighton Avenue Suite 101 Anniston, Alabama 36207 Phone: 256-240-7272 Fax: 256-240-7242 Breast Cancer in Women What is breast cancer? When abnormal cells grow uncontrollably, they
More informationWhy Choose Breast Radiology?
Why Choose Breast Radiology? Hannah Gay ST6, St George s Hospital BSBR exec committee trainee representative. Introduction Breast cancer is the most common cancer in the UK. Lifetime risk of 1 in 8 for
More informationBenign phyllodes tumour
Benign phyllodes tumour This leaflet tells you about benign phyllodes tumours. It explains what a benign phyllodes tumour is, and how it is diagnosed and treated. Benign breast conditions information provided
More informationMammography. The Lebanese Society of Obstetrics and Gynecology. Women s health promotion series
The Lebanese Society of Obstetrics and Gynecology Women s health promotion series Mammography When breast cancer is diagnosed at an early stage it could be treated and the patient would have a high chance
More informationBreast Cancer Staging
Breast Cancer Staging Symposium on Best Practice in Recording Cancer Stage Royal College of Pathologists 10 June 2011 Dr Gill Lawrence, Director Tel: 0121 415 8129 Fax: 0121 414 7712 Email: gill.lawrence@wmciu.nhs.uk
More informationRUTGERS CANCER INSTITUTE OF NEW JERSEY - ROBERT WOOD JOHNSON MEDICAL SCHOOL INTERDISCIPLINARY BREAST SURGERY FELLOWSHIP CORE EDUCATIONAL OBJECTIVES
RUTGERS CANCER INSTITUTE OF NEW JERSEY - ROBERT WOOD JOHNSON MEDICAL SCHOOL INTERDISCIPLINARY BREAST SURGERY FELLOWSHIP CORE EDUCATIONAL OBJECTIVES At the completion of Breast Fellowship training, the
More informationBreast Cancer Task Force of the Greater Miami Valley A collaborative effort of health care professionals and breast cancer survivors in the Greater
Breast Cancer Task Force of the Greater Miami Valley A collaborative effort of health care professionals and breast cancer survivors in the Greater Dayton Area Last Updated Fall 2014 TABLE OF CONTENTS
More informationBreast and Ovarian Cancer
Patient Education Breast and Ovarian Cancer Screening and detection The goal of screening for cancer is to find it as early as possible, when it is easiest to cure. This handout describes the symptoms
More informationDR AISHA A UMAR CHIEF CONSULTANT RADIOLOGIST NATIONAL HOSPITAL ABUJA.
DR AISHA A UMAR CHIEF CONSULTANT RADIOLOGIST NATIONAL HOSPITAL ABUJA. OUTLINE WHY DO WE IMAGE WHOM TO IMAGE WHEN TO IMAGE HOW TO IMAGE WHAT TO IMAGE WITH PERSONAL EXPERIENCE CONCLUSION/RECOMMENDATIONS
More information